Lie Åslund1, Mats Lekander1,2, Rikard K Wicksell1, Eva Henje3, Susanna Jernelöv1. 1. Department of Clinical Neuroscience, Karolinska Institutet, Sweden. 2. Stress Research Institute, Stockholm University, Sweden. 3. Department of Clinical Science, Umeå University, Sweden.
Abstract
BACKGROUND: Insomnia is common in adolescents and often comorbid with psychiatric disorders. This study evaluated changes in insomnia, sleep, and comorbid symptoms following cognitive-behavioral therapy for insomnia (CBT-I) in adolescents with comorbid psychiatric disorders and chronic pain. METHODS: In this non-controlled clinical pilot study, participants (n = 23, 78% female) were recruited from adolescent psychiatry and pediatric pain clinics. Assessments of self-reported insomnia, sleep onset latency, wake after sleep onset, total sleep time, sleep efficiency and depression, anxiety, functional disability, and pain intensity were completed at pre- and post-intervention and 3 months follow-up. RESULTS: From pre- to post-intervention, statistically significant improvements were found for insomnia symptoms (p < .001; d = 1.63), sleep onset latency (p < .001; d = 1.04), wake after sleep onset (p < .001; d = 0.38), total sleep time (p = .015; d = 0.22), sleep efficiency (p < .001; d = 1.00), depression (p < .001; d = 0.87), and anxiety (p = .001; d = 0.31). Only eight participants reported data at follow-up with maintained improvements for all measures. CONCLUSION: This study provides support that insomnia symptoms and sleep can improve following CBT-I delivered in a clinical setting and that co-occurring psychiatric symptoms can be reduced. The results should be interpreted with caution due to the uncontrolled conditions and limited sample size. Well-powered clinical trials are needed to validate the suggested effects.
BACKGROUND: Insomnia is common in adolescents and often comorbid with psychiatric disorders. This study evaluated changes in insomnia, sleep, and comorbid symptoms following cognitive-behavioral therapy for insomnia (CBT-I) in adolescents with comorbid psychiatric disorders and chronic pain. METHODS: In this non-controlled clinical pilot study, participants (n = 23, 78% female) were recruited from adolescent psychiatry and pediatric pain clinics. Assessments of self-reported insomnia, sleep onset latency, wake after sleep onset, total sleep time, sleep efficiency and depression, anxiety, functional disability, and pain intensity were completed at pre- and post-intervention and 3 months follow-up. RESULTS: From pre- to post-intervention, statistically significant improvements were found for insomnia symptoms (p < .001; d = 1.63), sleep onset latency (p < .001; d = 1.04), wake after sleep onset (p < .001; d = 0.38), total sleep time (p = .015; d = 0.22), sleep efficiency (p < .001; d = 1.00), depression (p < .001; d = 0.87), and anxiety (p = .001; d = 0.31). Only eight participants reported data at follow-up with maintained improvements for all measures. CONCLUSION: This study provides support that insomnia symptoms and sleep can improve following CBT-I delivered in a clinical setting and that co-occurring psychiatric symptoms can be reduced. The results should be interpreted with caution due to the uncontrolled conditions and limited sample size. Well-powered clinical trials are needed to validate the suggested effects.
Authors: Michael Gradisar; Michal Kahn; Gorica Micic; Michelle Short; Chelsea Reynolds; Faith Orchard; Serena Bauducco; Kate Bartel; Cele Richardson Journal: Nat Rev Psychol Date: 2022-06-20
Authors: Darlynn M Rojo-Wissar; David W Sosnowski; Maggie M Ingram; Chandra L Jackson; Brion S Maher; Candice A Alfano; Lisa J Meltzer; Adam P Spira Journal: Sleep Med Date: 2021-10-21 Impact factor: 4.842
Authors: Isa Okajima; Noriko Tanizawa; Megumi Harata; Sooyeon Suh; Chien-Ming Yang; Shirley Xin Li; Mickey T Trockel Journal: Int J Environ Res Public Health Date: 2021-12-24 Impact factor: 3.390